UPDATED Jun 19, 2024
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
BFRI | US$1.00 | 0% | -91.5% | US$5.1m | US$16.00 | PE-0.2x | E68.8% | n/a | ||
EYEN | US$0.63 | 0% | -74.8% | US$34.1m | US$9.00 | PS3885.7x | E31.1% | n/a | ||
ABIO | US$3.34 | 0% | 59.0% | US$48.5m | n/a | PB1.4x | n/a | n/a | ||
KNSA | US$18.20 | 0% | 12.3% | US$1.3b | US$30.67 | PE149.3x | E44.1% | n/a | ||
AEON | US$1.34 | 0% | -83.7% | US$52.4m | US$6.00 | PE-0.4x | S89.5% | n/a | ||
IDYA | US$37.27 | 0% | 47.3% | US$2.8b | US$54.45 | PS181.9x | E42.3% | n/a | ||
GOSS | US$0.54 | 0% | -58.6% | US$122.7m | US$6.09 | PB4.6x | E29.9% | n/a | ||
VTGN | US$3.31 | 0% | 83.9% | US$89.5m | US$14.00 | PS84.1x | E11.2% | n/a | ||
RPTX | US$3.63 | 0% | -68.7% | US$154.1m | US$15.33 | PS1.6x | E-22.7% | n/a | ||
DVAX | US$11.28 | 0% | -12.4% | US$1.5b | US$25.91 | PE160.1x | E42.9% | n/a | ||
PDSB | US$2.74 | 0% | -53.3% | US$100.5m | US$12.00 | PB2.7x | E6.0% | n/a | ||
KURA | US$19.77 | 0% | 84.4% | US$1.5b | US$30.42 | PB3x | E25.0% | n/a | ||
ARTL | US$1.25 | 0% | -35.5% | US$4.0m | US$16.67 | PB0.4x | E49.9% | n/a | ||
AVIR | US$3.49 | 0% | -12.8% | US$293.9m | US$5.50 | PB0.6x | E-14.8% | n/a | ||
HUMA | US$5.94 | 0% | 105.4% | US$706.8m | US$8.25 | PB27x | E46.7% | n/a | ||
UTHR | US$306.04 | 0% | 37.2% | US$13.6b | US$295.95 | PE12.9x | E7.0% | n/a | ||
DSGN | US$3.54 | 0% | -35.6% | US$200.0m | US$6.67 | PB0.7x | E-15.1% | n/a | ||
OVID | US$0.79 | 0% | -79.2% | US$55.9m | US$3.90 | PS118x | E1.1% | n/a | ||
ARQT | US$8.15 | 0% | -15.6% | US$943.5m | US$19.00 | PS8.9x | E66.3% | n/a | ||
CYCC | US$1.50 | 0% | -85.1% | US$2.2m | US$11.00 | PS4.9x | E67.2% | n/a | ||
CTMX | US$1.29 | 0% | -16.2% | US$100.5m | US$5.32 | PE6.1x | E-36.4% | n/a | ||
KPTI | US$0.93 | 0% | -54.0% | US$115.9m | US$5.21 | PE-0.8x | E35.2% | n/a | ||
UPC | US$2.30 | 0% | -14.9% | US$8.3m | n/a | PB0.2x | n/a | n/a | ||
ICCC | US$4.25 | 0% | -25.8% | US$33.2m | n/a | PS1.6x | n/a | n/a |